• Guideline Summary
  • NGC:009375
  • 2012 Oct

Psoriasis: the assessment and management of psoriasis.

  • Guideline Summary
  • NGC:010022
  • 1998 Oct (revised 2013 Sep)

Treatment of primary breast cancer. A national clinical guideline.

  • Guideline Summary
  • NGC:010900
  • 2016 Feb 10

Myeloma: diagnosis and management.

  • Guideline Summary
  • NGC:009196
  • 2012 Jun

Sickle cell acute painful episode: management of an acute painful sickle cell episode in hospital.

  • Guideline Summary
  • NGC:010026
  • 2006 Jun 20 (revised 2013 Jul 1)

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

  • Guideline Summary
  • NGC:009938
  • 2013 Jun

Clinical practice guideline: improving voice outcomes after thyroid surgery.

  • Guideline Summary
  • NGC:009869
  • 2013 Mar

Evidence-based clinical practice guideline: breast reconstruction with expanders and implants.

  • Guideline Summary
  • NGC:010562
  • 2014 Aug

EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy.

  • Guideline Summary
  • NGC:010699
  • 2014 Sep 29

Locoregional therapy of locally advanced breast cancer (LABC).

  • Guideline Summary
  • NGC:010713
  • 2014 Dec

An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.

  • Guideline Summary
  • NGC:010218
  • 2006 May (revised 2014 Feb)

The role of endoscopy in the evaluation and management of dysphagia.

  • Guideline Summary
  • NGC:010016
  • 2006 Oct (revised 2013 Sep)

Urinary incontinence: the management of urinary incontinence in women.

  • Guideline Summary
  • NGC:009797
  • 2000 Jan (revised 2013 May)

Fetal growth restriction.

  • Guideline Summary
  • NGC:010082
  • 2002 Aug (revised 2013 Jul)

Diagnosis and treatment of osteoporosis.

  • Guideline Summary
  • NGC:010829
  • 2015 Nov 12

Menopause: diagnosis and management.

  • Guideline Summary
  • NGC:009474
  • 2012 Nov

Treatments for overactive bladder: focus on pharmacotherapy.

  • Guideline Summary
  • NGC:009997
  • 2010 Aug (revised 2013 Jul)

Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes.

  • Guideline Summary
  • NGC:010177
  • 2013

ACR Appropriateness Criteria® thyroid carcinoma.